Studies point to the efficacy of regenerative therapy in improving muscle mass in older adults.

How can we accelerate the development of advanced medicines?

Looking back on 12 months of cell and gene therapy research.

Sitting Down With… Vered Caplan, CEO of Orgenesis, Israel.

The Cell and Gene Collective launches to help boost patient access and awareness of cell and gene therapies.

The COVID-19 vaccines demonstrate what’s possible when disease is tackled as a genuine priority.

To ensure the cell and gene therapy field advances with all stakeholders in mind, especially the patient, we need to talk – now.

A $4-billion acquisition, a key finding for sarcopenia drug development, and algorithmic efficiency… What’s new in advanced medicine?

A step closer to an off-the-shelf CAR T cell therapy.

Are seriously ill patients vulnerable to overestimating the benefits and underestimating the risks of gene editing studies?